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DNAa b s t r a c t
The RecQ helicase from Deinococcus radiodurans (DrRecQ) distinguishes from other helicases in that
it utilizes its three ‘helicase and RNaseD C-terminal’ domains (HRDC1, HRDC2 and HRDC3) to regu-
late its activity. These HRDC domains have different inﬂuence on the biochemical functions of
DrRecQ. Currently, only the structure of HRDC3 was reported. Here, we determined the NMR struc-
ture of the N-terminal-most HRDC1, revealing a potential DNA binding domain. Fluorescence anisot-
ropy assay indicates that HRDC1 has binding afﬁnity weaker than 70 lM to all DNA substrates
without any speciﬁcity. Biochemical assays suggested that HRDC1 cooperates with other domains
to enhance full-length DrRecQ interactions with DNA.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
RecQ proteins function as key DNA unwinding enzymes with
important roles in maintaining the stability of the genetic material
in all living organisms [1,2]. Mutations in three of the ﬁve human
recQ genes can lead to chromosomal and developmental abnormal-
ities, cancer progression and premature aging [3–5]. Recent studies
revealed that RecQ proteins retain genomic integrity through inter-
actions with a variety number of proteins and nucleic acid struc-
tures [1], which depends on the genome metabolic pathways [2].
The bacterial Deinococcus radiodurans (D. radiodurans) is an excel-
lent model to study the biological roles of RecQ proteins, for it
can survive a massive level of DNA-damaging radiation (as high
as 5000 Gy) without a loss of viability [6]. The c-radiation can in-
duce DNA double-strand breaks (DSBs) during exposure, which
are difﬁcult to be repaired as there’s no templates left behind to di-
rect DNA repair. However, in D. radiodurans, although many well-known DNA repair genes are conserved, there are no identiﬁable
homologs found for the recB and recC genes that encode the major
DSB repair machinery observed in Escherichia coli (E. coli) [7]. Thus,
a RecF-like repair pathway was thought to be central to keep geno-
mic integrity unchanged in D. radiodurans (identical to the RecF
pathway in E. coli) [8,9]. But the mechanism about how this path-
way is used in D. radiodurans to repair DNA damage still remains
unclear.
It was reported that almost all RecQ family members contain
the conserved domains, consisting of one Helicase domain, one
RecQ-conserved domain (RecQ-ct) and one HRDC domain [10],
each of them has its own structure and function. However, RecQ
from D. radiodurans (i.e., DrRecQ) includes three HRDC domains
in tandem at its C-terminus, different from other RecQ family
members. These three HRDC domains have different inﬂuences
on the biochemical functions of DrRecQ [11]. Therefore, the unu-
sual architecture of DrRecQ was suggested to address how RecF-
like DNA repair pathway works in D. radiodurans. So far, among
these three HRDC domains of DrRecQ, only the structure of the
C-terminal-most HRDC3 domain has been reported [12], which
shares an almost similar overall fold to the reported HRDC domains
from Saccharomyces cerevisiae (S. cerevisiae) Sgs1 [13], E. coli
(EcRecQ) [14], human Werner protein (WRN) [15] and human
Bloom syndrome protein (BLM) [16,17], indicating that HRDC
2636 S. Liu et al. / FEBS Letters 587 (2013) 2635–2642domains demonstrate different functions probably due to their low
sequence conservation (Fig. 1A). DrRecQ HRDC3 contains a promi-
nent acidic patch for possible inter-domain interactions to regulate
DrRecQ binding to DNA with structural speciﬁcity.
In this report, to probe how the N-terminal-most DrRecQ
HRDC1 domain regulates full-length DrRecQ biological functions,
we determined its solution structure at a very high resolution by
modern nuclear magnetic resonance (NMR) techniques. Then,
based on the structural information, we further examined its func-
tional roles in the interactions of the full-length DrRecQ with dif-
ferent DNA substrates by other biochemical assays.
2. Materials and methods
2.1. Different DrRecQ fragments cloning, expression and puriﬁcation
The DrRecQ HRDC1 (536–610 aa), RecQ-ct (405–513 aa), RecQ-
ct+HRDC1 (405–610 aa), DrRecQ610 (1–610 aa) and full-length
DrRecQ (Fig. 1B), and isotope 13C and 15N labeled HRDC1 were pre-
pared and puriﬁed as shown in Supplementary information.
2.2. NMR spectroscopy of DrRecQ HRDC1
All NMR experiments were performed at 293 K on a Varian
Unity Inova 600 spectrometer equipped with three channels andFig. 1. Structural features of DrRecQ HRDC1. (A) Sequences alignment of DrRecQ HRD
cerevisiae Rrp6 and S. cerevisiae Sgs1. The helices of DrRecQ HRDC1 were indicated on the
helices a1 and a3, the residue proline to limit orientation of the loop helices a3 and a4 w
DrRecQ domain variants described in this paper. Numbers indicated the ﬁrst and last
structures. (D and E) Ribbon representation and surface depiction of DrRecQ HRDC1 doma
and V604 were highlighted. (F and G) Ribbon representation and electrostatic surface opulse-ﬁeld gradient. The standard suite of experiments for assign-
ing 1H, 13C and 15N backbone and side chain chemical shifts and for
obtaining NOE-based distance restraints were collected [18,19],
including the two dimensional (2D) 13C-edited HSQC and 15N-edi-
ted HSQC; the three dimensional (3D) HNCA, HNCO, HNCACO,
HNCACB, CBCA(CO)NH, HBHA(CO)NH, 15N-resolved HSQC-TOCSY,
HCCH-TOCSY in both aliphatic and aromatic regions, 15N-resolved
HSQC-NOESY, 13C-resolved HSQC-NOESY for both aliphatic and
aromatic resonances, 2D (Hb)Cb(CcCd)Hd and (Hb)Cb(CcCdCe)He
spectra for correlation of Cb and Hd or He in aromatic ring used
in aromatic protons assignment [20]. All spectra were processed
with the program NMRPipe [21] and analyzed with the software
Sparky 3 (http://www.cgl.ucsf.edu/home/sparky/). The 1H chemi-
cal shifts were referenced to 2,2-dimethylsilapentane-5-sulfonic
acid (DSS), and the 13C- and 15N-resonances were indirectly refer-
enced to DSS.
2.3. NMR structure determination of DrRecQ HRDC1
Calculations were carried out using a standard simulated
annealing protocol implemented in the program XPLOR-2.19
(NIH version) [22]. Inter-proton distance restraints derived from
NOE intensities were grouped into three distance ranges 1.8–
2.9 Å, 1.8–3.5 Å and 1.8–6.0 Å, corresponding to strong, medium
and weak NOEs, respectively. The dihedral angles phi and psi wereC1, HRDC2, HRDC3, and HRDC domains from E. coli, human BLM, human WRN, S.
top of the sequences. The residues to form hydrophobic core, the hydrophobic linker
ere highlighted as pink, blue and green boxes, respectively. (B) Schematic diagram of
residue. (C) Backbone view of the ensemble of the 20 lowest-energy HRDC1 NMR
in. The helices are numbered. Six hydrophobic residues L544, L568, I571, L582, V600
f DrRecQ HRDC3. HRDC1 and HRDC3 in (D–G) were drawn in a same orientation.
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using the program TALOS [21,23]. Slowly exchanging amide pro-
tons, identiﬁed in the 2D 15N–1H HSQC spectra recorded after a
H2O buffer was exchanged to a D2O buffer, were used in the struc-
ture calculated with the NOE distance restraints to generate hydro-
gen bonds for the ﬁnal structure calculation, as done in the
literature [24]. A total of ten iterations (50 structures in the initial
eight iterations) were performed. 100 structures were computed in
the last two iterations, 20 conformers with the lowest energy were
used to represent the 3D structures (Fig. 1C). In this ensemble of
the simulated annealing 20 structures, there were no distance con-
straint violations more than 0.3 Å, and no torsion angle violations
more than 3. The ﬁnal 20 structures were evaluated with the pro-
grams PROCHECK_NMR and PROCHECK [25] and summarized in
Table 1. All structure ﬁgures were generated using the programs
PyMOL (http://pymol.org/) and MOLMOL [26].
2.4. Synthetic DNA substrates
All DNA strands were commercially synthesized at HPLC grade
(Shanghai Sangon Biological Engineering Technology and Service
Co. Ltd., China) with the following reported sequences [11]: o18
ssDNA (50-AAGCA CAATT ACCCA CGC-30), o30 ssDNA (50-GCGTG
GGTAA TTGTG CTTCA ATGGA CTGAC-30), oHolliday1 (50-GCCGT
GATCA CCAAT GCAGA TTGAC GAACC TTTGC CCACG T-30), oHolli-
day2 (50-GACGT GGGCA AAGGT TCGTC AATGGACTGA CAGCT
GCATG G-30), oHolliday3 (50-GCCAT GCAGC TGTCA GTCCA TTGTC
ATGCT AGGCC TACTG C-30), oHolliday4 (50-GGCAG TAGGC CTAGC
ATGAC AATCT GCATT GGTGA TCACG G-30). The 18-bp dsDNA (orTable 1
Experimental restraints and structural statistics for DrRecQ HRDC1 domain.
HRDC1 experimental restraints and structural statistics





Sequential range (i  j = 1) 392
Medium range (1<|i  j| = <5) 338
Long range (|i  j| > 5) 103
Hydrogen bonds (pairs) 26




R.m.s deviations versus the mean structure (Å)
All backbone atoms 0.91 ± 0.18
All heavy atoms 1.23 ± 0.17
Backbone atoms (secondary structure) 0.52 ± 0.19
Heavy atoms (secondary structure) 0.99 ± 0.19
R.m.s. deviations from the experimental restraints
NOE distances (Å) 0.03 ± 0.0007
Dihedral angles (deg) 0.36 ± 0.06
R.m.s. deviations from idealized geometry
Bonds (Å) 0.0018 ± 6.01  105
Angles (deg) 0.27 ± 0.0092
Impropers (deg) 0.25 ± 0.0070
Final energy (kJ/mol)
Ebond 3.93 ± 0.25
Eangles 23.28 ± 1.61
ENOE 101.74 ± 5.00
EL–J 252.82 ± 6.62
Ramachandran analysis (%)
Residues in most favored regions 94.4
Residues in additionally allowed regions 3.2
Residues in generously allowed regions 2.3
Residues in disallowed regions 0.130-bp dsDNA) was formed by mixing o18 (or o30) ssDNA with
its own complementary strand at equal molar ratio, and then an-
nealed by heating at 95 C for 5 min and slowly cooling down to
room temperature. The 30-OH DNA (also called as dup-30 dsDNA)
substrate was created by heating and slow cooling an equal molar
mixture of o30 and o18 to room temperature for about 1 h, forming
an 18-bp duplex region with a 12-base 30-single-stranded exten-
sion. Holiday Junction (HJ) substrate was created by annealing
equal molar amounts of oHolliday1, oHolliday2, oHolliday3, and
oHolliday4, which forms a structure with four 20-base pair duplex
arms extending from a central four-way junction.
For ﬂuorescence anisotropy DNA binding studies, 30-ﬂuorescein
labeled o30 and 50-ﬂuorescein labeled oHolliday1 oligonucleotides
were incorporated into the 30-OH and HJ DNA structures. 30-ﬂuo-
rescein-labeled o18 and 30-ﬂuorescein-labeled o30 were used as
ssDNA, and were also used to make ﬂuorescein-labeled dsDNA
substrates with their complementary strands.
2.5. Fluorescence anisotropy DNA binding assay
The binding afﬁnities of the DrRecQ fragments including
HRDC1, RecQ-ct+HRDC1, DrRecQ610 and full-length DrRecQ, and
their mutants (HRDC1 K553A and H564Amutants, RecQ-ct+HRDC1
H564A, DrRecQ K553A and H564A mutants) to different DNA sub-
strates were determined by ﬂuorescence anisotropy assay (Fig. 2).
All diluted protein solutions (in buffer: 20 mM Tris, pH 8.0, 50 mM
NaCl, 1 mM b-mercaptoethanol, 1 mM MgCl2, 0.1 g/l of bovine
serum albumin and 4% (v/v) glycerol) were incubated with
100 nM 30-ﬂuoroscein labeled o18, or 30-ﬂuoroscein labeled o30,
or 30-ﬂuoroscein labeled 18-bp dsDNA, or 30-ﬂuoroscein labeled
30-bp dsDNA, or 30-ﬂuoroscein labeled 30-OH dsDNA, or 50-ﬂuores-
cein labeled HJ DNA at room temperature in a total reaction vol-
ume of 200 ll. The ﬂuorescence anisotropy in each case was
measured at 25 C using a Genios Pro FP system (TECAN Co.) with
490 nm excitation and 535 nm emission wavelengths, respectively.
The ﬁnal dissociation constants (KD) were determined [27] by a
nonlinear least squares analysis with the equation F ¼ Fo
ðFo  Ff Þ½D=2Þðb ðb2  4½DNA½PÞ
1=2 
, where b = KD + [D] + [P],
[D] is the ﬁxed concentration of different DNA substrates, [P] is
the concentration of DrRecQ fragments or their mutants, F and Fo
are the observed ﬂuorescence anisotropy of DNA substrates in
the presence of and in the absence of DrRecQ fragments or their
mutants, respectively, and Ff is the observed maximal ﬂuorescence
anisotropy value in the presence of DrRecQ variants or their mu-
tants. Data shown are averaged values of three repeated measure-
ments. The binding afﬁnities values were summarized in Table 2.
2.6. NMR titration and backbone 15N relaxation of DrRecQ HRDC1
To determine DNA binding sites on HRDC1, NMR chemical shifts
perturbation assay was performed at the buffer condition similar
to that for structural determination. For correctly examining
NMR chemical shifts changes of HRDC1 in the presence of three
different DNA substrates (o18 ssDNA, 18-bp dsDNA and 30-OH
dsDNA), the assignments of cross peaks in two dimensional (2D)
1H–15N HSQC spectra were conﬁrmed by performing NMR step-
wise titration experiments through increasing the stoichiometric
ratio of HRDC1: DNA as follows 1:0, 1:0.1, 1:0.2, 1:0.4, 1:0.6,
1:0.8, 1:1.1, 1:1.2, 1:1.4, 1:1.6, 1:1.8 and 1:2, and collecting
1H–15N HSQC spectra after each addition. Combined 15N–1H chem-
ical shift differences were calculated using the equation
Dd ¼ 0:125  DdNð Þ2 þ Dd2H
h i1=2
(Fig. 3).
To determine the ﬂexibility of HRDC1 backbone atoms, the
measurements of the nitrogen relaxation times, T1, T2 and
Fig. 2. Fluorescence anisotropy assay for KD measurement binding to DNA. (A–C) HRDC1 and its K553A and H564A mutants; (D) RecQ-ct; [E and F] RecQ-ct+HRDC1 and its
H564A mutant; [G]DrRecQ610; [H-J]full-length DrRecQ and its K553A and H564A mutants.
Table 2
Dissociation constants (KD) of different DrRecQ fragments, and their mutants binding to DNA.
o18 ssDNA (lM) o30 ssDNA (lM) 18-bp dsDNA (lM) 30-bp dsDNA (lM) 3’-OH dsDNA (lM) HJ DNA (lM)
HRDC1 87.05 ± 5.70 72.63 ± 9.18 81.55 ± 6.26 111.60 ± 17.37 175.9 ± 34.70 ND
HRDC1_K553A 104.0 ± 19.45 100.60 ± 16.07 ND ND 90.53 ± 29.37 ND
HRDC1_H564A 107.6 ± 25.36 ND ND ND 269.20 ± 160.4 ND
RecQ-ct 43.58 ± 4.48 36.30 ± 13.23 ND ND 62.62 ± 9.33 63.44 ± 8.46
RecQ-ct+HRDC1 0.40 ± 0.04 0.18 ± 0.02 0.34 ± 0.06 0.46 ± 0.06 0.22 ± 0.02 4.83 ± 0.58
RecQ-ct+HRDC1 H564A 0.48 ± 0.10 0.18 ± 0.01 0.71 ± 0.11 0.82 ± 0.15 0.36 ± 0.08 1.18 ± 0.17
DrRecQ610 0.58 ± 0.09 0.27 ± 0.04 1.30 ± 1.44 0.97 ± 0.16 0.40 ± 0.05 1.93 ± 0.31
DrRecQ 0.072 ± 0.0054 0.0028 ± 0.0012 0.83 ± 0.092 1.35 ± 0.14 0.11 ± 0.011 0.56 ± 0.073
DrRecQ K553A 0.18 ± 0.019 0.0056 ± 0.0011 1.39 ± 0.122 2.28 ± 0.19 0.16 ± 0.019 0.97 ± 0.13
DrRecQ H564A 0.14 ± 0.021 0.092 ± 0.018 1.62 ± 0.29 1.76 ± 0.39 0.11 ± 0.006 0.86 ± 0.16
⁄ND means that data is not able to be correctly detected.
2638 S. Liu et al. / FEBS Letters 587 (2013) 2635–264215N–1H NOEs were performed at 293 K for HRDC1 on a Varian
INOVA 600 MHz spectrometer. Ten different values for the
relaxation delay were used for the T1 (delays 40, 60, 80, 100, 140,
200, 260, 360, 530 and 760 ms) and T2 (Carr–Purcell–Meiboom–
Gill ) mixing times 10, 30, 50, 70, 90, 130, 150, 170 and 190 ms)
relaxation experiments. The T1 and T2 values were obtained by
nonlinear squares ﬁts through program GraphPad Prism 5. The
15N–1H NOE values were calculated as the ratio of the intensities
of paired 15N–1H correlation peaks from interleaved spectra
acquired with and without 1H presaturation during a recycle time
of 3 s (Fig. 4).3. Results and discussion
3.1. DrRecQ HRDC1 is a potential DNA binding domain
In total, assignments of more than 98% of the main-chain and
96% of the side-chain atoms of the residues 536–610 were com-
pleted. The solution structure of DrRecQ HRDC1 was determined
by a conventional heteronuclear NMR method using 15N-labeled
or 13C/15N-labeled protein. 1204 distance restraints from NOE, 26
pairs of hydrogen bonds and 96 dihedral angle restraints for back-
bone u and w angles were used to calculate solution structure. A
Fig. 3. Chemical shift changes of DrRecQ HRDC1 upon interacting with o18 ssDNA
(A), 18-bp dsDNA (B) and 30-OH dsDNA (C), respectively. The residues with
chemical shift changes more than 0.15 ppm were displayed in red.
S. Liu et al. / FEBS Letters 587 (2013) 2635–2642 2639best-ﬁt superposition of the ensemble of the 20 lowest-energy
structures represented in Fig. 1C was displayed with the RMSD val-
ues of 0.91 ± 0.18 Å for global backbone atoms and 1.23 ± 0.17 Å for
global heavy atoms. The RMSD values are 0.52 ± 0.19 Å for the
backbone (N, CA and CO) atoms and 0.99 ± 0.19 Å for all heavy
atoms in the well-ordered second structure regions, respectively.
The Ramachandran plot displays 94.4% of the residues in themost-favored regions and 3.2% residues in additionally allowed re-
gions (Table 1), indicating the structures are reasonable. The back-
bone relaxation experiments suggest that the whole HRDC1
conformation is rigid except its residues in its C-terminus
(Fig. 4), similar to that of human BLM HRDC domain [16].
DrRecQ HRDC1 consists of 6 a-helices (helices a1: A538-L555;
a2: P559-I562; a3: D565-E573; a4: H579-G583; 5: R591-A595;
a6: D598-G609) connected by short loops. The ﬁrst helix confor-
matiaon is slightly distorted because the residue P539 is the
second residue located in the beginning of the helix. The 2nd
a-helix is located in a hydrophobic loop (Fig. 1D). Structural homo-
log searching by Dali [28] suggests that DrRecQ HRDC1 resembles
conventional DNA binding domains. DrRecQ HRDC1 can be super-
imposed with DrRecQ HRDC3 (pdb code 2rhf, Fig. 1F and G) [12],
EcRecQ HRDC (pdb code 1wud) [14], human WRN HRDC (pdb
codes 2e1e and 2e1f) [15], human BLM HRDC (pdb codes 2kv2
and 2rrd) [16–17] and Sgs1 HRDC (pdb code 1d8b) [13] with RMSD
values of 3.04 Å, 2.77 Å, 3.11 Å, 2.97 Å and 3.62 Å for Ca atoms con-
tained in the secondary structure regions, respectively. The confor-
mational differences are mainly located in the ﬂexible regions
between a1 and a3 helices, and between a3 and a5 helices. The
interactions among the conserved key hydrophobic residues
L544, L568, I571, L582, V600 and V604 force the helical structures
into a tight bundle (Fig. 1A and D). In comparison, the residues
L758, L782, L785, L796, I814 and I818 in DrRecQ HRDC3 domain
form an almost identical hydrophobic core. In the ﬁve other HRDC
homologues, this hydrophobic core is composed of Leu, Leu, Leu (or
Met), Leu (or Met or Val or Phe), Ile (or Val or Phe) and Ile (or Leu,
except that in Sgs1, Ser is hydrophilic) (Fig. 1A). In DrRecQ HRDC3,
it’s well known that the distinguished ionic interaction between
E768 and R813 in the different helices stabilizes the conformation
of DrRecQ HRDC3 [12], but this ion interaction is obviously absent
in DrRecQ HRDC1 structure, because negatively charged E768 in
DrRecQ HRDC3 is conserved in HRDC1 (i.e., E554), but positively
charged R813 in DrRecQ HRDC3 is not (the corresponding residue
in HRDC1 is negatively charged E599). Therefore, the conformation
of DrRecQ HRDC1 might be mainly stabilized by the inter-helix
hydrophobic interactions in the hydrophobic core formed by the
residues L544, L568, I571, L582, V600 and V604 in the different
helices.
In addition, the hydrophobic linker between helices a1 and a3
begins with 557-LPPY-560 in DrRecQ HRDC1, opposed to 771-
YSAF-774 in DrRecQ HRDC3, 1173-VPPA-1176 in human WRN
HRDC, 552-VPPY-555 in EcRecQ HRDC, 1295-PPVG-1298 in Sgs1
HRDC and 1235-VHYF-1238 in human BLM HRDC (Fig. 1). An a-he-
lix (a2) is shown up in this linker in both DrRecQ HRDC1 and
HRDC3 domains, whereas a loop is formed in Sgs1 HRDC [13],
and a 310 helix is observed in E. coli HRDC [14], WRN HRDC [15]
and BLM HRDC [16,17]. Thus, the conformation of this hydrophobic
linker is highly divergent. The 310 helix conformer was suggested
necessary to expose the aromatic ring of Y555 in EcRecQ HRDC,
or of F1238 in human BLM HRDC into solvent for interaction with
ssDNA [14,16]. In DrRecQ HRDC1, Y560 resides at the similar posi-
tion in the a-helix of its hydrophobic loop, thus, this residue may
also be important for DrRecQ HRDC1 binding to ssDNA. This sug-
gestion accords with the observation of the big chemical shifts per-
turbation of the residues around Y560 of HRDC1 upon interaction
with o18 ssDNA (Fig. 3A). In addition, the residue P576 located in
the loop between helices a3 and a4 of DrRecQ HRDC1 is highly
conserved across different HRDC domains (Fig. 1A). In each struc-
ture, it was found that this proline kinks loop conformation in-
wards and inverts the side-chains of the surrounding residues
outwards. In DrRecQ HRDC1, P576 limits the loop conformation,
probably allowing the inter-helix hydrophobic interactions easier
to form between residues L568, I571, L582, V600 and V604. These
hydrophobic interactions make the global folding of the protein
Fig. 4. Backbone dynamics data for DrRecQ HRDC1 domain. (A) T1 longitudinal relaxation time; (B) T2 transverse relaxation time; (C) 1H–15N heteronuclear NOE values.
2640 S. Liu et al. / FEBS Letters 587 (2013) 2635–2642more rigid, which is consistent with the relaxation data of the
backbone atoms, as shown in Fig. 4.
3.2. Dynamics study of the DrRecQ HRDC1 domain
Clearly, the N-terminus is more rigid than the C-terminus,
which might be resulted from the bending of the ﬁrst helix
(Fig. 4), as P539 is the 2nd residue in the beginning ofthis helix.
The conformational information of the loop between helices a3
and a4 was also observed in the NMR relaxation results. Within
the standard deviations, the T1, T2 and the average NOE values
for the residues L574, R575, G577 and S578 are almost the same
with those detected for the residues in the helices, indicating that
P576 limits this loop conformation. Moreover, the residues in the
hydrophobic linker between helices a1 and a3, which includes he-lix a2, also have T1, T2 and NOE values almost similar to those for
the residues in the helices a1, a2, and a3. This observation is differ-
ent from that in BLM HRDC [16]. In BLM HRDC, Y1237 has slightly
higher ﬂexibility than the other residues in the hydrophobic linker
[16]. In DrRecQ HRDC1, we supposed that, probably due to two Pro
residues close to it, Y560 demonstrates rigid conformation in this
hydrophobic loop.
3.3. DrRecQ HRDC1 interacts with different DNA substrates
Since Dali structural homolog searching reveals that HRDC1 is a
potential DNA binding domain, we thus measured its binding afﬁn-
ities to different DNA substrates by using ﬂuorescence anisotropy
assay. The results demonstrate that DrRecQ HRDC1 has only weak
binding afﬁnities to different DNA substrates (in all cases, the bind-
S. Liu et al. / FEBS Letters 587 (2013) 2635–2642 2641ing afﬁnity constant KD > 70 lM, Table 2 and Fig. 2A) without any
signiﬁcant speciﬁcity. In DrRecQ HRDC1 structure, the side-chain
of positively charged residues, such as R545, R548, K553, K569,
R591 and K592, are extending outwards of the HRDC1 surface
(Fig. 1E), thus they may be important for DNA binding. To ﬁnd
which residue is involved in the interaction of HRDC1 with DNA,
NMR chemical shift perturbation of HRDC1 backbone atoms (HN,
N) was probed in the presence of o18 ssDNA, 18-bp dsDNA and
30-OH dsDNA. The results suggest that the DNA binding sites are
mainly concentrated on the regions of DrRecQ HRDC1 C-terminal
half of helix a1 (i.e., residues 545–553), whole helix a2 and N-ter-
minal half of helix a3 (i.e., residues 559–570) (Fig. 3). Residues
with chemical shifts perturbation more than 0.15 ppm in three
cases and located on the surface, for example, R545, K553 and
H564, were thus chosen for further mutational analysis. HRDC1
R545A, K553A and H564A variants were designed. Among them,
except that R545A was unable to be expressed in a soluble form,
other two variants were obtained in a large scale for further ﬂuo-
rescence anisotropy binding studies (Figs. 2B and C). The NMR
1H–15N HSQC experiments and the CD spectra on the mutants
(Supplementary information, Figs. S1 and 2) suggested that the
mutations from K553 or H564 to A553 or A564 did not generate
structural problem. The 2D 1H–15N LR-HSQC spectra acquired at
pH 7.0, 7.5 and 8.0 (Supplementary information, Fig. S3) indicated
the side-chain of H564 is neutral, we thus supposed that H564
might interact with DNA through hydrophobic or p–p interaction,
or hydrogen-bond interaction. Within our expectation, these muta-
tions abolish the binding afﬁnities of HRDC1 to 18-bp dsDNA and
30-bp dsDNA, revealing dsDNA may also interact with the hydro-
phobic link containing helix a2. Mutation from H564 to A564 also
makes the binding afﬁnity of HRDC1 to o30 ssDNA non-detectable,
further conﬁrming that the hydrophobic linker is a key site for
ssDNA binding. This observation is identical with the fact that
ssDNA mainly binds with the 310 helix in this hydrophobic linker
of BLM HRDC [16]. HRDC1 has a binding afﬁnity value (KD) about
200 lM to 30-OH dsDNA, which makes the mutations have almost
no obvious effects on the interaction between HRDC1 and 30-OH
dsDNA (KD = 100–300 lM).
3.4. DrRecQ HRDC1 cooperates with other domains to largely enhance
DNA binding
To investigate how much the N-terminal-most HRDC1 contrib-
utes to the interactions between full-length DrRecQ and DNA sub-
strates, we thus compared the binding afﬁnities of different
DrRecQ fragments, including RecQ-ct, RecQ-ct+HRDC1, DrRecQ610,
and full-length DrRecQ, to all DNA substrates. We ﬁrst measured
the binding afﬁnities of RecQ-ct to all DNA substrates (Fig. 2D),
which indicated that RecQ-ct interacts with ssDNA, 30-OH dsDNA
and HJ DNA with almost similar KD values (about 40–60 lM) to
those of DrRecQ HRDC1 (Table 2). Moreover, RecQ-ct does not bind
to dsDNA. In comparison, RecQ-ct+HRDC1, containing a RecQ-ct
domain and HRDC1 domain, demonstrates much stronger binding
abilities to all DNA substrates (Fig. 2E and Table 2). The KD values of
RecQ-ct+HRDC1 binding to o18 ssDNA, o30 ssDNA, 18-bp dsDNA
and 30-bp dsDNA are increased by 200–250 folds, and that to 30-
OH dsDNA is increased by 800 folds, thus, RecQ-ct domain works
together with HRDC1 to enhance DNA binding [11]. Mutation on
possible DNA binding site in HRDC1 domain (for example,
H564A, Fig. 2F) does not affect the interaction of RecQ-ct+HRDC1
with DNA (KD values are kept almost unchanged compared to na-
tive RecQ-ct+HRDC1), which probably is resulted from the fact that
this residue might be only one of the key DNA binding sites of
DrRecQ HRDC1. DrRecQ610, which includes helicase domain,
RecQ-ct domain and HRDC1 domain, has binding afﬁnities to
ssDNA, dsDNA, 30-OH dsDNA and HJ DNA substrates almost similarto RecQ-ct+HRDC1 (Fig. 2G), suggesting that helicase domain is not
involved in DNA binding. This observation is consistent with the
fact that the helicase domain has only ATPase activity and plays
major roles in unwinding DNA [29-33]. Compared to DrRecQ610,
as shown in Fig. 2H, the full-length DrRecQ has binding afﬁnities
to ssDNA increased by about 10–100 folds, to 30-OH dsDNA and
HJ DNA increased by 4 folds, indicating that DrRecQ HRDC2 and
HRDC3 domains could work together with other functional motifs
to enhance DrRecQ interactions with ssDNA (the binding afﬁnity to
o18 ssDNA was increased by 8 folds, while that to o30 ssDNA was
improved by about 100 folds.), 30-OH dsDNA and HJ DNA (in both
cases, KD was increased by about 4 folds), but not with dsDNA.
Since the experimental buffer conditions are exactly the same,
we’re still not clear why the observation of full-length DrRecQ
and DrRecQ610 binding afﬁnities to ssDNA is not identical with
those observed by Keck and others [11]. Mutations at residues
K553 and H564 in HRDC1 region of the full-length DrRecQ
decrease the binding afﬁnities of full-length DrRecQ to ssDNA by
about 2–30 folds, but have no evident effects in binding of full-
length DrRecQ to dsDNA, 30-OH dsDNA and HJ DNA (Fig. 2I and
J), revealing that these sites in HRDC1 may be especially critical
for full-length DrRecQ binding to ssDNA.
In summary, our structure and biochemical data revealed that
DrRecQ HRDC1 is a potential DNA binding domain. It coordinates
with other domains to substantially strengthen DrRecQ interac-
tions with DNA. In full-length DrRecQ, the residue H564 in HRDC1
domain may be important for full-length DrRecQ interaction with
ssDNA.
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